Fludrocortisone (Acetate)

Fludrocortisone (Acetate) is a potent steroid with both glucocorticoid and mineralocorticoid activity. Fludrocortisone (Acetate) is the most widely used mineralocorticoid. Chemically Fludrocortisone (Acetate) is identified as 9-Fluoro-11β, 17, 21-trihydroxypregn-4-ene-3, 20-dione 21-acetate. It acts on the kidneys to retain sodium and increases the excretion of potassium in the urine. Fludrocortisone (Acetate) is used in the treatment of addison''s disease.'

Brands
Adult Dose
Dose: 0.714 to 2.857 ug/kg
Single Dose: 1.8 (1.7855)
Frequency: 24 hourly
Route: PO
Instructions: Initially in Morning
Neonatal
Dose: 5 ug/kg
Single Dose: 5 (5)
Frequency: 24 hourly
Route: Oral
Instructions:
Paedriatic
Dose: 5 ug/kg
Single Dose: 5 (5)
Frequency: 24 hourly
Route: Oral
Instructions: -
Characteristics
Fludrocortisone (Acetate) also known as Fluohydrisone Acetate, Fluohydrisone Acetate, Fluohydrisone Acetate. . It is of Synthetic origin and belongs to Steroid. It belongs to Mineralocorticoid agonist pharmacological group on the basis of mechanism of action and also classified in Corticosteroid Adrenal pharmacological group.The Molecular Weight of Fludrocortisone (Acetate) is 422.50.
Contraindications
Fludrocortisone (Acetate) is contraindicated in conditions like Hypertension,Hypokalaemia,Hypoalbuminaemia,Fluid retention.
Effects
The severe or irreversible adverse effects of Fludrocortisone (Acetate), which give rise to further complications include Peptic ulceration, Myopathy, Adrenal suppression, Diabetogenesis, Impaired immune response.Fludrocortisone (Acetate) produces potentially life-threatening effects which include Myocardial infarction, Cardiac failure, Cardiac stroke. which are responsible for the discontinuation of Fludrocortisone (Acetate) therapy.The signs and symptoms that are produced after the acute overdosage of Fludrocortisone (Acetate) include Edema, Fluid retension, Pleural effusion, Cardiac enlargement.The symptomatic adverse reactions produced by Fludrocortisone (Acetate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Muscle weakness, Hypokalemia, Edema.
Indications
Fludrocortisone (Acetate) is primarily indicated in conditions like Adrenal insufficiency, As an antidote to methotrexate, Congenital adrenal hyperplasia, Electrolyte disorder, Mineralocorticoid replacement in adrenocortical insuffenciency, Orthostatic hypotension, Peripheral ischaemia.
Interactions
Fludrocortisone (Acetate) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementCarbamazepineDesmopressin (Acetate)Frusemide or FurosemideLypressinNatamycinConcurrent use may increase the toxicity, therefore concomitant use is contraindicated. NateglinideConcurrent use may reduce the hypoglycemic action of Nateglinide.Phenytoin (Na)PrimidoneRifampicinSodium SalicylateVasopressin These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
false-negative result with nitrobluetetrazolium test for bacterial infection
Risks
Drug should not be given to Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Tab Store in a well closed container, Below 40°C.
Warnings
Fludrocortisone should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examine regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.